Sakuraba A - Search Results

1

Is there a role for apheresis in gastrointestinal disorders?

Hibi T, Sakuraba A. Hibi T, et al. Among authors: sakuraba a. Nat Clin Pract Gastroenterol Hepatol. 2005 May;2(5):200-1. doi: 10.1038/ncpgasthep0168. Nat Clin Pract Gastroenterol Hepatol. 2005. PMID: 16265186 No abstract available.

2

Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.

Wang J, Prenner J, Wang W, Sakuraba A, Hyman N, Dalal S, Hurst R, Cohen RD, Umanskiy K, Shogan BD, Alpert L, Rubin DT, Colwell J, Pekow J. Wang J, et al. Among authors: sakuraba a. Aliment Pharmacol Ther. 2020 Jun;51(12):1365-1372. doi: 10.1111/apt.15766. Epub 2020 May 7. Aliment Pharmacol Ther. 2020. PMID: 32383278

3

Per oral endoscopic myotomy as salvage therapy in patients with achalasia refractory to endoscopic or surgical therapy is technically feasible and safe: Systematic review and meta-analysis.

Hashimoto R, Inoue H, Shimamura Y, Sakuraba A, Tomizawa Y. Hashimoto R, et al. Among authors: sakuraba a. Dig Endosc. 2020 Nov;32(7):1042-1049. doi: 10.1111/den.13643. Epub 2020 Mar 20. Dig Endosc. 2020. PMID: 32012360 Review.

4

Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis.

Gondal B, Haider H, Komaki Y, Komaki F, Micic D, Rubin DT, Sakuraba A. Gondal B, et al. Among authors: sakuraba a. World J Gastrointest Endosc. 2020 May 16;12(5):159-171. doi: 10.4253/wjge.v12.i5.159. World J Gastrointest Endosc. 2020. PMID: 32477450 Free PMC article.

5

Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.

Anyane-Yeboa A, Sato T, Sakuraba A. Anyane-Yeboa A, et al. Among authors: sakuraba a. J Intern Med. 2020 Oct;288(4):479-480. doi: 10.1111/joim.13117. Epub 2020 Jun 15. J Intern Med. 2020. PMID: 32452046 Free article. No abstract available.

6

Animal models of inflammatory bowel disease.

Hibi T, Ogata H, Sakuraba A. Hibi T, et al. Among authors: sakuraba a. J Gastroenterol. 2002;37(6):409-17. doi: 10.1007/s005350200060. J Gastroenterol. 2002. PMID: 12108674 Review. No abstract available.

7

Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.

Sato T, Kanai T, Watanabe M, Sakuraba A, Okamoto S, Nakai T, Okazawa A, Inoue N, Totsuka T, Yamazaki M, Kroczek RA, Fukushima T, Ishii H, Hibi T. Sato T, et al. Among authors: sakuraba a. Gastroenterology. 2004 Mar;126(3):829-39. doi: 10.1053/j.gastro.2003.12.011. Gastroenterology. 2004. PMID: 14988837

8

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T. Matsuoka K, et al. Among authors: sakuraba a. Am J Gastroenterol. 2007 Feb;102(2):331-7. doi: 10.1111/j.1572-0241.2006.00989.x. Epub 2006 Dec 11. Am J Gastroenterol. 2007. PMID: 17156136

9

A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.

Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T. Sakuraba A, et al. J Gastroenterol. 2008;43(1):51-6. doi: 10.1007/s00535-007-2129-6. Epub 2008 Feb 24. J Gastroenterol. 2008. PMID: 18297436 Clinical Trial.

10

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease.

Naganuma M, Sakuraba A, Hisamatsu T, Ochiai H, Hasegawa H, Ogata H, Iwao Y, Hibi T. Naganuma M, et al. Among authors: sakuraba a. Inflamm Bowel Dis. 2008 Sep;14(9):1259-64. doi: 10.1002/ibd.20457. Inflamm Bowel Dis. 2008. PMID: 18393375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results